Latest News and Press Releases
Want to stay updated on the latest news?
-
The case alleges that NuScale failed to disclose that it entrusted its NPM commercialization to an entity that lacked significant prior experience.
-
The Soleno complaint alleges that Soleno Phase 3 clinical trial program for DCCR had downplayed, misrepresented, and/or concealed safety concerns.
-
The case alleges Boston Scientific misled investors about its US EP segment's growth and competitive risks.
-
The monday.com complaint alleges that defendants misled investors by providing materially flawed statements of confidence and growth projections.
-
The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.
-
The case alleges Stellantis overstated its ability to capitalize on the electrification market.
-
The case alleges that Driven Brands misled investors as to its financial condition and the effectiveness of its internal controls over financial reporting.
-
The case alleges ImmunityBio materially overstated Anktiva’s capabilities.
-
The case alleges Enphase Energy misled investors about channel inventory and its ability to mitigate the 25D tax credit’s termination.
-
The case alleges Navan failed to disclose it would increase its sales and marketing expenses by 39% just months after the IPO.